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Endoscopic Diagnostic System Using Autofluorescence
S. TAKEHANA*, M. KANEKO and H. MIZUNO
Product Development Department Endoscope Division, Olympus Optical Co., Ltd., 2951 Ishikawa-cho Hachioji-shi,
Tokyo, 192-8507 Japan
A fluorescence imaging system (Xillix LIFE Lung Fluorescence Endoscopy system) using
fluorescence for the accurate diagnosis and early detection of lesions through an endosocope
has been developed. This system has applied an optical diagnostic technology to functionally
diagnose lesions which have been difficult to morphologically recognize or are occult with
conventional endoscope. The benefit of this system in the diagnosis oflung cancer has already
been confirmed in theUS and Japan, and feasibility ofthe system in the gastric intestinal field
has also been evaluated.
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INTRODUCTION
By adopting spectroscopic technologies such as
fluorescence of light, absorption of light, and
Raman-scattered light, abnormalities of living
tissue can be detected on the cellular or macroscopic
level. Recently, a new technology, optical diagnosis,
has been calling attention that applies the above
spectroscopic technologies to the "living body as it
is" to functionally diagnose lesions that have been
difficult to be determined by conventional morpho-
logical diagnosis [1-4]. Particularly, research and
development of "fluorescence imaging" and "opti-
cal biopsy" have been actively implemented: fluo-
rescence imaging has been developed in view ofearly
detection and diagnosis of lesions, that have been
difficult to detect with conventional endoscopy.
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This has been done by means of displaying in vivo
video images endoscopically using autofluorescence
emitted from living tissue. Emitted autofluorescence
is a result of when a light of specific wavelength
(light between UV and blue region) excites tissue.
This can be done without using drugs such as
photosensitizing substances [5-7]. Optical biopsy
has been developed to provide pathological diag-
nosis with an optical fiber inserted through an
endoscope channel, in place of biopsy [8,9]. These
autofluorescence technologies are expected to be
established in the near future as a new diagnosing
method in conjunction with an endoscopic fluores-
cence imaging endoscopes.
As stated above, development of an endoscopic
fluorescence imaging system has been conducted to
endoscopically display image of autofluorescence
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to provide new diagnostic form by exploiting the
difference between the spectrums of normal and
abnormal tissue [10,11].
MATERIALS AND METHODS
Overview of the Device
The LIFE-Lung system was first developed in the
world by Xillix Technologies Corp., Canada, in
1990, and the system was found to be useful in
detecting early lesion [10-12]. This system has
received FDA approval in 1996. Olympus Optical
Co., Ltd. started selling the product worldwide in
1997. The outlook appearance of the system is
shown in Fig. 1.
System Components
Components ofthis system are shown in Fig. 2. This
system is comprised of an Illumination Console of
He-Cd laser (442 nm) which produces blue light, a
LIFE camera which includes ICCDs, high-sensitiv-
ity imaging devices, that detect subtle changes in
autofluorescence, an Imaging Console which pro-
cesses and displays the autofluorescence images,
and a commercially available endoscope system.
An excitation light source of 442nm wavelength
produces blue light, delivers to the tissue surface
through an endosope. Then, the low light level
autofluorescence emitted from the tissue is ampli-
fied through an endosope. Then, the low light level
autofluorescence emitted from the tissue is amp-
lified by 5,000 to 10,000 times and detected by
the LIFE camera attached to the eyepiece of the
endoscope. This LIFE camera installs two high-
sensitivity CCDs that capture green and red auto-
fluorescence, and those captured image signals are,
respectively, processed by the image processing unit
in real-time, and then displayed on the monitor as a
color image (Fig. 2) (Table I).
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FIGURE 2 Schematic diagram of endoscopic fluoresccnce
system.
FIGURE Outlook appearance of the system.
TABLE Specifications of this system
Illumination console
Laser
Wavelength
Light output
LIFE camera
Imaging device
Video I/O
Imaging console
Image management
He-Cd laser
442nm
15 30mW
ICCD
RGB signal
Digital filing
SVHS video cassette recorder
Video printerLIFE FLUORESCENCE ENDOSCOPY SYSTEM 61
Specifications and Features of the System
Specifications of this system is shown in the Table I.
As stated in the above, this system does not require
administration of drugs such as photosensitized
substances for the early detection and diagnosis of
lesion, thus there is no need to anticipate side-
effects. Also, the laser output of this system is kept
low and its safety with regard to bioeffects has been
confirmed. Therefore, this system can be usedjust as
with conventional white-light bronchoscopy.
Principle of Autofluorescence
Fluorescence imaging is designed for the early
detection and diagnosis oflesions by endoscopically
illuminating light against tissue, processing the
emitted fluorescence into images, and displaying
such lesions that have been difficult to detect or
diagnose under conventional white-light endoscopy
as the difference of fluorescence intensity or color
tone.
Figure 3 is the result of autofluorescence spec-
trummeasured ofnormal and abnormal tissuewhen
blue light was illuminated to those living tissues
through an optical fiber inserted into the endoscope
channel [5,6]. Figure 3 shows autofluorescence
spectrum of normal bronchial tissue and CIS
(Carcinoma in situ) using an excitation wavelength
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FIGURE 3 Autofluorescence spectrum in normal and
abnormal tissue in the bronchus.
of 442nm (He-Cd laser). While in normal tissue,
the shape of fluorescence spectrum demonstrated
its peak in green with gradual decrease at longer
wavelength, the shape of overall spectrum in
abnormal tissue was rather flat with decreased
spectrum centering to the short wavelength side
and with a small rise in red side.
Although the precise mechanism of different
autofluorescence spectrums detected in normal
and cancerous tissue has not been established, the
following has been considered: It has been consid-
ered highly possible that collagen, flavoprotein,
NADH, and porphyrin, known as autofluorescence
substances existing in the living tissue, have some-
thing to do with the different spectrums as has the
tissue architecture and the blood content.
With this LIFE-Lung, it has been considered that
the system observes the following differences based
on the wavelength excited/detected from the above
substances.
(1) Cancerous tissue has higher metabolism than
normal tissue and therefore, its blood volume
increases while oxygen concentration in the cells
decreases. Because of the increase of blood volume
and accumulation character which is specific to
cancer, the amount of porphyrin is increased (red
fluorescence is increased), and at the same time,
flavin is reduced (green fluorescence is decreased) as
oxygen conoentration is decreased.
(2) Autofluorescnece is intensely produced from
submucosa stroma (ex. collagen), but epithelium,
mucosa, and cancerous tissue emit very little
fluorescence. Because of thicker epithelium and
mucosa in cancerous region than in normal region
and of the presence of cancer, fluorescence of green
region is intensely absorbed. (Tissue permeability of
light is higher in red region than in green region:
100-1000 times greater per cm.)
RESULTS
Clinical Applications
A Multi-Center Study LC01 conducted from 1994-
1995 in North America reports that in 173 patients,62 S. TAKEHANA et al.
detection ratio for moderate/severe dysplasia or
greaterwas improved from 24.6% (withLIFE-Lung
compared to that with conventional white-light
endoscopy alone) to 66.9%, and that their speci-
ficity were 92.0% and 70.2%, respectively, without
significant difference.
In Japan as well, Yokomise et al. and Ikeda et al.
conducted a study on the benefits ofthe LIFE-Lung
from 1995 fall to 1996 spring [13,14]. Yokomise et al.
and Ikeda et al. each conducted a comparative study
on 30 patients with existing or suspected lung cancer
comparing with the result of conventional white-
light bronchoscopy and both admitted effectiveness
of LIFE-Lung. Yokomise et al. reported that
compared to conventional white-light broncho-
scopy alone, detection ratio of metaplasia and
cancer was improved from 65% to 90%, and that
specificity was improved from 71% to 77.4% by
using autofluorescence bronchoscopy jointly with
conventional bronchoscopy. Ikeda et al. also report
that detection ratio for metaplasia was improved
from 28% to 96% by the joint use of autofluores-
cence bronchoscopy with conventional bronchos-
copy than by the latter only. Since a screening test
using sputum cytology has been carried out partic-
ularly in Japan, the LIFE-Lung is expected to serve
in diagnosis of early lung cancer in subjects who
have turned out to be positive in the sputum
cytology.
Application to GI
Figure 4 shows autofluorescence spectrum of
normal and abnormal (precancerous) tissue when
the light of437nm (a combination of high-pressure
Halogen lamp and a blue band-pass filter) was
emitted into the esophagus. Autofluorescence spec-
trum similar to that in the bronchi is shown. Based
on this fact, Olympus Optical Co., Ltd. and Xillix
Technologies Corp. has jointly been developing a
fluorescence endoscopy system for gastric intestinal
tract (LIFE-GI imaging system) based on LIFE-
Lung.
In the gastrointestinal tracts such as stomach and
colon where body cavity is larger than in bronchi
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FIGURE 4 Autofluorescence .spectrum in normal and
abnormal tissue in the esophagus.
and whose mucosa contains a lot of capillary blood
vessels, good-quality fluorescence image cannot be
acquired with the system designed for bronchi due to
the shortage ofexcited light intensity. Therefore, by
combining mercury lamp and blue-exiting filter to
blue light source, twice as much intensity of light as
that ofHe-Cd laser can be obtained at the tip of the
endoscope, which enabled autofluorecence observa-
tion in the large body cavity of gastrointestinal
tracts. By using a device in which this blue light
source is installed, we have applied this technology
to the esophagus, stomach, and colon [6,15-25].
Watanabe et al. applied this device in patients
(total 12 lesions) who were suspected of remnant
after the endoscopic treatment for stomach cancer,
and reported that they were able to identify the
presence and location of remnant in 3 cases by
biopsies performed under fluorescence observation
that they were not able to recognize under conven-
tional white-light endoscopy [24]. Also, Yano et al.
applied this device to 47 patients with stomach
cancer and reported that they have succeeded in
finding second-lesion in one case which were not
possible to indicate under conventional white-light
endoscopy [25]. Based on these past clinical trials,
feasibility ofLIFE-GI in detecting lesions that have
been difficult to recognize with conventional white-
light endoscopy has been suggested. It is necessaryLIFE FLUORESCENCE ENDOSCOPY SYSTEM 63
in the future to further increase the number of cases
and clarify clinical benefits.
DISCUSSION
Various studies have long been carried out in an
attempt to diagnose cancer by using fluorescence,
but observing the autofluorescence was especially
difficult due to its weak intensity. However, recent
improvement in illumination and in high-sensitivity
camera has enabled real-time display and observa-
tion of even subtle changes in autofluorescence
endoscopically. The technology was developed
and put into practice using the technology devel-
oped in the LIFE-Lung system.
The past clinical findings suggests the feasibility
of autofluorescence endoscopy to become an effec-
tive means of diagnosis for the detection and
localization of precancerous tissue such as micro
cancer and metaplasia in the bronchi and gastro-
intestinal tracts. We are also expecting that in the
future, combination of this technology for early
diagnosis and minimal invasive treatment such as
endoscopic treatment and/or PDT will increase
opportunity for patients to undergo high QOL
treatment ofminimally invasive.
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